100 related articles for article (PubMed ID: 35927723)
21. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
[TBL] [Abstract][Full Text] [Related]
22. The determination of the knowledge level and behavior of Turkish women from various occupations about human papillomavirus, cervical cancer, and pap smear test.
Cimke VS; Borekci G
J Cancer Res Ther; 2019; 15(6):1235-1244. PubMed ID: 31898654
[TBL] [Abstract][Full Text] [Related]
23. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract][Full Text] [Related]
24. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
25. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
26. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
27. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
28. Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.
Ilangovan K; Kobetz E; Koru-Sengul T; Marcus EN; Rodriguez B; Alonzo Y; Carrasquillo O
J Womens Health (Larchmt); 2016 Sep; 25(9):944-51. PubMed ID: 26890012
[TBL] [Abstract][Full Text] [Related]
29. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
30. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
32. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
34. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
Lefeuvre C; Pivert A; Guillou-Guillemette HL; Lunel-Fabiani F; Veillon P; Le Duc-Banaszuk AS; Ducancelle A
J Infect; 2020 Aug; 81(2):248-254. PubMed ID: 32413363
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France.
Reques L; Rolland C; Lallemand A; Lahmidi N; Aranda-Fernández E; Lazzarino A; Bottero J; Hamers F; Bergeron C; Haguenoer K; Launoy G; Luhmann N
BMC Womens Health; 2021 May; 21(1):221. PubMed ID: 34039341
[TBL] [Abstract][Full Text] [Related]
36. Assessing Canadian women's preferences for cervical cancer screening: A brief report.
Zhu P; Tatar O; Haward B; Griffin-Mathieu G; Perez S; Smith L; Brotherton J; Ogilvie G; Rosberger Z
Front Public Health; 2022; 10():962039. PubMed ID: 35968487
[TBL] [Abstract][Full Text] [Related]
37. Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.
Shim SH; Kim H; Sohn IS; Hwang HS; Kwon HS; Lee SJ; Lee JY; Kim SN; Lee K; Chang S
J Gynecol Oncol; 2017 Sep; 28(5):e63. PubMed ID: 28657224
[TBL] [Abstract][Full Text] [Related]
38. Cervical cancer screening outcomes in public health facilities in three states in Nigeria.
Lawson O; Ameyan L; Tukur Z; Dunu S; Kerry M; Okuyemi OO; Yusuf Z; Fasawe O; Wiwa O; Hebert KS; Joseph JT; Nwokwu UE; Okpako O; Chime CI
BMC Public Health; 2023 Sep; 23(1):1688. PubMed ID: 37658293
[TBL] [Abstract][Full Text] [Related]
39. Knowledge and Perceptions about Cervical Cancer and HPV Screening in Women in Rural Areas of Ecuador: A Qualitative Research Study.
Bautista-Valarezo E; Vega Crespo B; Maldonado-Rengel R; Espinosa ME; Neira VA; Verhoeven V
Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078764
[TBL] [Abstract][Full Text] [Related]
40. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Ogilvie GS; Smith LW; van Niekerk DJ; Khurshed F; Krajden M; Saraiya M; Goel V; Rimer BK; Greene SB; Hobbs S; Coldman AJ; Franco EL
Int J Cancer; 2013 Dec; 133(12):2934-43. PubMed ID: 23754203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
